SEARCH

SEARCH BY CITATION

References

  • 1
    Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, et al. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 2005; 44: 279-304.
  • 2
    Zhou S, Chan E, Lim LY, Boelsterli UA, Li SC, Wang J, et al. Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4. Curr Drug Metab 2004; 5: 415-442.
  • 3
    Fontana RJ, Lown KS, Paine MF, Fortlage L, Santella RM, Felton JS, et al. Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology 1999; 117: 89-98.
  • 4
    Evans WE, McLeod HL. Pharmacogenomics—drug disposition, drug targets and side effects. N Engl J Med 2003; 348: 538.
  • 5
    Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 1999; 369: 11-23.
  • 6
    Leichtman A, Watkins PB. The molecular basis of cyclosporin A metabolism, pharmacokinetics, and drug interactions. Organ Cell Transplant 1999; 2: 177-182.
  • 7
    Lee JE, van Heeswijk R, Alves K, Smith F, Garg V. Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. Antimicrob Agents Chemother 2011; 55: 4569-4574.
  • 8
    Telaprevir [package insert]. Boston, MA: Vertex Pharmaceuticals; 2011.
  • 9
    Boceprevir [package insert]. Whitehouse Station, NJ: Merck Laboratories; 2011.
  • 10
    Poordad F, Lawitz E, Gordon SC, Bourliere M, Vierling JM, Paynard T, et al. Concomitant medication use in patients with hepatitis C genotype 1 treated with boceprevir (BOC) combination therapy [abstract]. Hepatology 2011; 54: 799–800.
  • 11
    Sherman KE, Rockstroh J, Dietrich DT, Soriano V, Girard P, McCallister S, et al. Telaprevir in combination with peginterferon alfa-2a/ribavirin in HCV/HIV coinfected patients: 24-week treatment interim analysis [abstract]. Hepatology 2011; 54: 1431–1432.
  • 12
    Garg V, van Heeswijk R, Lee JE, Alves K, Nadkarni P, Luo X. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus. Hepatology 2011; 54: 20-27.
  • 13
    Jain AK, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl 2002; 8: 841-845.
  • 14
    Jain AB, Venkataramanan R, Eghtesad B, Marcos A, Ragni M, Shapiro R, et al. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl 2003; 9: 954-960.